Lindsay A Rhodes1, Carrie E Huisingh2, Adam E Quinn2, Gerald McGwin3, Frank LaRussa4, Daniel Box5, Cynthia Owsley2, Christopher A Girkin2. 1. Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: lindsayrhodes@uabmc.edu. 2. Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 3. Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama. 4. Walmart Vision Center #1481, Birmingham, Alabama. 5. Walmart Vision Center #715 and Global Eye Care PC, Tuscaloosa, Alabama.
Abstract
PURPOSE: To examine if racial differences in Bruch's membrane opening minimum rim width (BMO-MRW) in spectral-domain optical coherence tomography (SDOCT) exist, specifically between people of African descent (AD) and European descent (ED) in normal ocular health. DESIGN: Cross-sectional study. METHODS: Patients presenting for a comprehensive eye examination at retail-based primary eye clinics were enrolled based on ≥1 of the following at-risk criteria for glaucoma: AD aged ≥40 years, ED aged ≥50 years, diabetes, family history of glaucoma, and/or pre-existing diagnosis of glaucoma. Participants with normal optic nerves on examination received SDOCT of the optic nerve head (24 radial scans). Global and regional (temporal, superotemporal, inferotemporal, nasal, superonasal, and inferonasal) BMO-MRW were measured and compared by race using generalized estimating equations. Models were adjusted for age, sex, and BMO area. RESULTS: SDOCT scans from 269 eyes (148 participants) were included in the analysis. Mean global BMO-MRW declined as age increased. After adjusting for age, sex, and BMO area, there was not a statistically significant difference in mean global BMO-MRW by race (P = .60). Regionally, the mean BMO-MRW was lower in the crude model among AD eyes in the temporal, superotemporal, and nasal regions and higher in the inferotemporal, superonasal, and inferonasal regions. However, in the adjusted model, these differences were not statistically significant. CONCLUSIONS: BMO-MRW was not statistically different between those of AD and ED. Race-specific normative data may not be necessary for the deployment of BMO-MRW in AD patients.
PURPOSE: To examine if racial differences in Bruch's membrane opening minimum rim width (BMO-MRW) in spectral-domain optical coherence tomography (SDOCT) exist, specifically between people of African descent (AD) and European descent (ED) in normal ocular health. DESIGN: Cross-sectional study. METHODS:Patients presenting for a comprehensive eye examination at retail-based primary eye clinics were enrolled based on ≥1 of the following at-risk criteria for glaucoma: AD aged ≥40 years, ED aged ≥50 years, diabetes, family history of glaucoma, and/or pre-existing diagnosis of glaucoma. Participants with normal optic nerves on examination received SDOCT of the optic nerve head (24 radial scans). Global and regional (temporal, superotemporal, inferotemporal, nasal, superonasal, and inferonasal) BMO-MRW were measured and compared by race using generalized estimating equations. Models were adjusted for age, sex, and BMO area. RESULTS:SDOCT scans from 269 eyes (148 participants) were included in the analysis. Mean global BMO-MRW declined as age increased. After adjusting for age, sex, and BMO area, there was not a statistically significant difference in mean global BMO-MRW by race (P = .60). Regionally, the mean BMO-MRW was lower in the crude model among AD eyes in the temporal, superotemporal, and nasal regions and higher in the inferotemporal, superonasal, and inferonasal regions. However, in the adjusted model, these differences were not statistically significant. CONCLUSIONS: BMO-MRW was not statistically different between those of AD and ED. Race-specific normative data may not be necessary for the deployment of BMO-MRW in ADpatients.
Authors: Boris Povazay; Bernd Hofer; Boris Hermann; Angelika Unterhuber; James E Morgan; Carl Glittenberg; Susanne Binder; Wolfgang Drexler Journal: J Biomed Opt Date: 2007 Jul-Aug Impact factor: 3.170
Authors: Lindsay A Rhodes; Carrie Huisingh; John Johnstone; Massimo Fazio; Brandon Smith; Mark Clark; J Crawford Downs; Cynthia Owsley; Michael J A Girard; Jean Martial Mari; Christopher Girkin Journal: Invest Ophthalmol Vis Sci Date: 2014-11-20 Impact factor: 4.799
Authors: Christopher K S Leung; Marco Yu; Robert N Weinreb; Cong Ye; Shu Liu; Gilda Lai; Dennis S C Lam Journal: Ophthalmology Date: 2012-01-20 Impact factor: 12.079
Authors: Alexandre S C Reis; Glen P Sharpe; Hongli Yang; Marcelo T Nicolela; Claude F Burgoyne; Balwantray C Chauhan Journal: Ophthalmology Date: 2012-01-04 Impact factor: 12.079
Authors: Vishva M Danthurebandara; Glen P Sharpe; Donna M Hutchison; Jonathan Denniss; Marcelo T Nicolela; Allison M McKendrick; Andrew Turpin; Balwantray C Chauhan Journal: Invest Ophthalmol Vis Sci Date: 2014-12-11 Impact factor: 4.799
Authors: Balwantray C Chauhan; Vishva M Danthurebandara; Glen P Sharpe; Shaban Demirel; Christopher A Girkin; Christian Y Mardin; Alexander F Scheuerle; Claude F Burgoyne Journal: Ophthalmology Date: 2015-07-18 Impact factor: 12.079
Authors: Stuart K Gardiner; Ruojin Ren; Hongli Yang; Brad Fortune; Claude F Burgoyne; Shaban Demirel Journal: Am J Ophthalmol Date: 2013-11-13 Impact factor: 5.258
Authors: Christopher Bowd; Linda M Zangwill; Robert N Weinreb; Christopher A Girkin; Massimo A Fazio; Jeffrey M Liebmann; Akram Belghith Journal: Am J Ophthalmol Date: 2018-09-07 Impact factor: 5.258
Authors: Lucas A Torres; Jayme R Vianna; Faisal Jarrar; Glen P Sharpe; Makoto Araie; Joseph Caprioli; Shaban Demirel; Christopher A Girkin; Masanori Hangai; Aiko Iwase; Jeffrey M Liebmann; Christian Y Mardin; Toru Nakazawa; Harry A Quigley; Alexander F Scheuerle; Kazuhisa Sugiyama; Hidenobu Tanihara; Goji Tomita; Yasuo Yanagi; Claude F Burgoyne; Balwantray C Chauhan Journal: Acta Ophthalmol Date: 2018-06 Impact factor: 3.761
Authors: Elise V Taniguchi; Eleftherios I Paschalis; Dejiao Li; Kouros Nouri-Mahdavi; Stacey C Brauner; Scott H Greenstein; Angela V Turalba; Janey L Wiggs; Louis R Pasquale; Lucy Q Shen Journal: Clin Ophthalmol Date: 2017-12-08
Authors: Haomin Luo; Hongli Yang; Stuart K Gardiner; Christy Hardin; Glen P Sharpe; Joseph Caprioli; Shaban Demirel; Christopher A Girkin; Jeffrey M Liebmann; Christian Y Mardin; Harry A Quigley; Alexander F Scheuerle; Brad Fortune; Balwantray C Chauhan; Claude F Burgoyne Journal: Invest Ophthalmol Vis Sci Date: 2018-05-01 Impact factor: 4.799
Authors: Linda Yi-Chieh Poon; Hussein Antar; Edem Tsikata; Rong Guo; Georgia Papadogeorgou; Madeline Freeman; Ziad Khoueir; Ramon Lee; Eric Shieh; Huseyin Simavli; Christian John Que; Johannes F de Boer; Teresa C Chen Journal: Transl Vis Sci Technol Date: 2018-11-27 Impact factor: 3.283
Authors: Camila S Zangalli; Jayme R Vianna; Alexandre S C Reis; Jamil Miguel-Neto; Claude F Burgoyne; Balwantray C Chauhan; Vital P Costa Journal: PLoS One Date: 2018-12-18 Impact factor: 3.240
Authors: Hussein Antar; Edem Tsikata; Kitiya Ratanawongphaibul; Jing Zhang; Eric Shieh; Ramon Lee; Madeline Freeman; Georgia Papadogeorgou; Huseyin Simavli; Christian Que; Alice C Verticchio Vercellin; Ziad Khoueir; Johannes F de Boer; Teresa C Chen Journal: J Glaucoma Date: 2019-11 Impact factor: 2.503